VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 103 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 6.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $141,000 | -48.7% | 54,298 | -18.8% | 0.00% | – |
Q2 2021 | $275,000 | -51.8% | 66,889 | -44.9% | 0.00% | -100.0% |
Q1 2021 | $571,000 | -2.7% | 121,399 | +47.6% | 0.00% | 0.0% |
Q4 2020 | $587,000 | -36.4% | 82,225 | -5.0% | 0.00% | -50.0% |
Q3 2020 | $923,000 | +10.3% | 86,545 | +30.2% | 0.00% | 0.0% |
Q2 2020 | $837,000 | +25.5% | 66,480 | -9.3% | 0.00% | 0.0% |
Q1 2020 | $667,000 | -36.1% | 73,287 | -2.5% | 0.00% | 0.0% |
Q4 2019 | $1,044,000 | +651.1% | 75,128 | +831.6% | 0.00% | – |
Q3 2019 | $139,000 | +44.8% | 8,064 | +58.2% | 0.00% | – |
Q3 2018 | $96,000 | -5.0% | 5,097 | 0.0% | 0.00% | – |
Q2 2018 | $101,000 | +5.2% | 5,097 | 0.0% | 0.00% | – |
Q1 2018 | $96,000 | -31.4% | 5,097 | -38.3% | 0.00% | – |
Q4 2017 | $140,000 | -23.5% | 8,258 | -6.8% | 0.00% | – |
Q3 2017 | $183,000 | +72.6% | 8,864 | -25.3% | 0.00% | – |
Q2 2017 | $106,000 | +6.0% | 11,864 | +57.7% | 0.00% | – |
Q1 2017 | $100,000 | -48.5% | 7,521 | -49.6% | 0.00% | – |
Q4 2016 | $194,000 | – | 14,909 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
Birchview Capital, LP | 33,000 | $310,000 | 0.29% |